BIIB

Biogen
D

BIIB

Arincen57/100B

Biogen stock buybacks 1989–2026

Biogen spent 0.00 USD buying back its shares in Q3 FY2026, the three months to 30 September 2026, with no change to compare on the same quarter a year before. Biogen spent 0.00 USD buying back its shares in fiscal year 2025, with no change to compare on the year before.

Last updated 9 Nov 2026 · Next report 5 Feb 2027

Stock buybacks

Growth

Fiscal yearPeriod endingStock buybacksGrowthDividends paidFree cash flow
TTM30 Sept 2026————
FY202531 Dec 20250.00—0.002.05B
FY202431 Dec 20240.00—0.002.52B
FY202331 Dec 20230.00-100.00%0.001.24B
FY202231 Dec 2022750.00M-58.33%0.001.14B
FY202131 Dec 20211.80B-73.05%0.003.38B
FY202031 Dec 20206.68B+13.82%0.003.81B
FY201931 Dec 20195.87B+34.82%0.006.56B
FY201831 Dec 20184.35B+218.78%0.005.42B
FY201731 Dec 20171.37B+36.54%0.003.68B
FY201631 Dec 20161.00B-80.00%0.003.91B
FY201531 Dec 20155.00B+463.84%0.003.07B
FY201431 Dec 2014886.78M+121.52%0.002.65B
FY201331 Dec 2013400.31M-59.35%0.00-1.16B
FY201231 Dec 2012984.72M+97.74%0.001.63B
FY201131 Dec 2011497.98M-76.03%0.001.48B
FY201031 Dec 20102.08B+176.58%0.001.45B
FY200931 Dec 2009751.17M+1.66%0.00909.25M
FY200831 Dec 2008738.94M-75.30%0.001.29B
FY200731 Dec 20072.99B+833.96%0.00736.53M
FY200631 Dec 2006320.27M-0.72%0.00642.96M
FY200531 Dec 2005322.59M-56.08%0.00571.13M
FY200431 Dec 2004734.43M—0.00358.22M
FY200331 Dec 20030.00-100.00%0.00-82.04M
FY200231 Dec 2002135.00M+52.92%0.00101.17M
FY200131 Dec 200188.28M-70.59%0.00120.82M
FY200031 Dec 2000300.19M+51.83%0.00166.82M
FY199931 Dec 1999197.72M+201.63%0.00185.96M
FY199831 Dec 199865.55M+836.43%0.00134.23M
FY199731 Dec 19977.00M—0.0062.08M
FY199631 Dec 19960.00—0.00-19.10M
FY199531 Dec 19950.00—0.00-40.86M
FY199431 Dec 19940.00—0.00-8.78M
FY199331 Dec 19930.00—0.0036.80M
FY199231 Dec 19920.00—0.0033.70M
FY199131 Dec 19910.00—2.90M-2.50M
FY199031 Dec 19900.00—5.90M-400.00K
FY198931 Dec 19890.00—2.70M-10.60M

Figures in USD. Free cash flow is operating cash flow less capital expenditure; owner earnings take off only the spending that keeps the business as it is, not the spending to grow it (an estimate by Financial Modeling Prep). Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

The money spent buying back the company's own shares in each period, from the cash flow statement.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Cash flow

Common questions about Biogen's buybacks

Source: Financial Modeling Prep